ストックスクリーナーアプリを入手
6.77
2.17%
-0.15
アフターアワーズ：
6.77
前日終値:
$6.92
開ける：
$6.97
24時間の取引高:
1.02M
Relative Volume:
0.33
時価総額：
$753.23M
収益：
$42.51M
当期純損益:
$-116.49M
株価収益率:
-6.0446
EPS:
-1.12
ネットキャッシュフロー:
$-120.82M
1週間 パフォーマンス:
+2.42%
1か月 パフォーマンス:
+14.55%
6か月 パフォーマンス:
+174.09%
1年 パフォーマンス:
-27.98%
1日の値動き範囲:
$6.761
$7.01
1週間の範囲:
$6.265
$7.15
52週間の値動き範囲:
$1.03
$12.02
Tango Therapeutics Inc Stock (TNGX) Company Profile
TNGX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TNGX
Tango Therapeutics Inc
|
6.77 | 769.92M | 42.51M | -116.49M | -120.82M | -1.12 |
|
VRTX
Vertex Pharmaceuticals Inc
|
392.79 | 100.07B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.41 | 59.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
448.91 | 58.03B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
653.83 | 39.93B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
321.36 | 36.82B | 3.81B | -644.79M | -669.77M | -6.24 |
Tango Therapeutics Inc Stock (TNGX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-07-17 | 開始されました | Jefferies | Buy |
| 2024-04-04 | 開始されました | Cantor Fitzgerald | Overweight |
| 2024-02-12 | 開始されました | Piper Sandler | Overweight |
| 2023-12-08 | 開始されました | B. Riley Securities | Buy |
| 2022-10-20 | アップグレード | H.C. Wainwright | Neutral → Buy |
| 2021-09-20 | 開始されました | SVB Leerink | Outperform |
すべてを表示
Tango Therapeutics Inc (TNGX) 最新ニュース
Analyzing Tango Therapeutics Inc. with risk reward ratio charts2025 Technical Overview & Fast Entry High Yield Stock Tips - Newser
What’s next for Tango Therapeutics Inc. stock priceWeekly Investment Report & Entry Point Strategy Guides - Newser
Using Python tools to backtest Tango Therapeutics Inc. strategiesDollar Strength & High Conviction Investment Ideas - Newser
Advanced analytics toolkit walkthrough for Tango Therapeutics Inc.Quarterly Market Review & Long-Term Growth Portfolio Plans - Newser
Tango Therapeutics Inc. recovery potential after sell off2025 Price Momentum & Daily Market Momentum Tracking - Newser
What Fibonacci levels say about Tango Therapeutics Inc. rebound2025 Trading Recap & Technical Entry and Exit Alerts - Newser
Why Tango Therapeutics Inc. stock attracts strong analyst attention2025 Top Decliners & AI Driven Price Predictions - Newser
What machine learning models say about Tango Therapeutics Inc.Market Sentiment Report & Daily Profit Focused Screening - Newser
Tango Therapeutics Inc. stock chart pattern explainedJuly 2025 Summary & Free Technical Confirmation Trade Alerts - Newser
Applying Elliott Wave Theory to Tango Therapeutics Inc.July 2025 Opening Moves & Fast Entry and Exit Trade Plans - Newser
How moving averages guide Tango Therapeutics Inc. tradingEarnings Performance Report & Risk Managed Trade Strategies - Newser
Price action breakdown for Tango Therapeutics Inc.Market Risk Summary & Technical Buy Zone Confirmations - Newser
Technical Charts Suggest Momentum Shift in Tango Therapeutics Inc. - sundaytimes.kr
Applying big data sentiment scoring on Tango Therapeutics Inc.July 2025 Gainers & Free Growth Oriented Trading Recommendations - Newser
Full technical analysis of Tango Therapeutics Inc. stockBull Run & Verified Trade Idea Suggestions - Newser
B. Riley Forecasts Increased Earnings for Tango Therapeutics - Defense World
Is Tango Therapeutics Inc. gaining market shareJuly 2025 Action & Stepwise Entry and Exit Trade Signals - kangso.co.kr
Tango Therapeutics, Inc. (NASDAQ:TNGX) Shares Acquired by XTX Topco Ltd - Defense World
Tango Therapeutics Inc. stock chart pattern explained [Weekly Trend Recap]Growth Focused Stock Pick Reports - Newser
Is Tango Therapeutics Inc. stock a value trapBig Profit Trading Alerts - thegnnews.com
What candlestick patterns are forming on Tango Therapeutics Inc.Free Reliable Chart-Based Trade Entries - Newser
Tango Therapeutics Inc. Company Revenue and Profit Trends: A Deep DivePattern Breakout Prediction for Short Term - Newser
Need To Know: Analysts Are Much More Bullish On Tango Therapeutics, Inc. (NASDAQ:TNGX) - 富途牛牛
How high can Tango Therapeutics Inc. stock price go in 2025Oversold Reversal Picks with Buy Zone - Newser
Will Tango Therapeutics Inc. see short term momentumTrade Plan With Low Risk High Return - Newser
Tango Therapeutics Inc (TNGX) 財務データ
収益
当期純利益
現金流量
EPS
Tango Therapeutics Inc (TNGX) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Barry Douglas | General Counsel |
Feb 05 '25 |
Sale |
3.16 |
2,556 |
8,081 |
66,014 |
| Beckman Daniella | Chief Financial Officer |
Feb 04 '25 |
Sale |
2.99 |
4,284 |
12,801 |
154,232 |
| Beckman Daniella | Chief Financial Officer |
Feb 05 '25 |
Sale |
3.16 |
3,948 |
12,481 |
150,284 |
| Crystal Adam | See Remarks |
Feb 04 '25 |
Sale |
2.99 |
7,432 |
22,207 |
165,061 |
| Crystal Adam | See Remarks |
Feb 05 '25 |
Sale |
3.16 |
6,851 |
21,659 |
158,210 |
| Weber Barbara | Chief Executive Officer |
Feb 04 '25 |
Sale |
2.99 |
9,778 |
29,217 |
1,631,264 |
| Weber Barbara | Chief Executive Officer |
Feb 05 '25 |
Sale |
3.16 |
9,013 |
28,494 |
1,622,251 |
| Rothenberg Mace | Director |
Nov 18 '24 |
Buy |
3.78 |
10,000 |
37,800 |
31,250 |
| Rothenberg Mace | Director |
Nov 14 '24 |
Buy |
3.62 |
10,000 |
36,200 |
21,250 |
| EcoR1 Capital, LLC | 10% Owner |
Nov 06 '24 |
Sale |
3.28 |
1,494,558 |
4,896,023 |
11,836,178 |
0.41%
0.88%
大文字化:
|
ボリューム (24 時間):